BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• FDA

  W. L. Gore & Associates, Inc. Receives Approval to Market GORE EXCLUDER(R) AAA Endoprosthesis and GORE TAG(R) Thoracic Endoprosthesis in Canada

  November 19, 2008

   · 

  4 min read
• Deals

  NitroMed, Inc. and Archemix Corporation Announce Merger Agreement

  November 19, 2008

   · 

  14 min read
• BioMidwest

  Riverain Medical Announces International Availability of Its OnGuard Computer-Aided Detection Technology and SoftView Enhanced Chest Imaging Technology

  November 19, 2008

   · 

  2 min read
• BioMidwest

  New Research Shows Microphage Inc. Test Accurately and Rapidly Detects Serious Bacterial Infections

  November 19, 2008

   · 

  4 min read
• Policy

  Tissue Genesis, Inc. Applies CE Mark to Its Adult Stem Cell Isolation System

  November 19, 2008

   · 

  7 min read
• Biotech Bay

  Collaborative Drug Discovery, Inc. Receives Bill & Melinda Gates Foundation Grant to Support the Development of a Database to Accelerate Discovery of New Therapies Against Tuberculosis

  November 19, 2008

   · 

  3 min read
• Drug Development

  Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia

  November 19, 2008

   · 

  4 min read
• FDA

  AstraZeneca PLC Stock Falls as Teva Pharmaceutical Industries Limited (JOBS) Receives First U.S. Approval for Generic Pulmicort Respules(R); Commences Commercial Launch

  November 19, 2008

   · 

  3 min read
• Biotech Bay

  Jazz Pharmaceuticals, Inc. Cancels Presentation Planned for November 19, 2008 at Lazard Capital Markets 5th Annual Healthcare Conference

  November 19, 2008

   · 

  1 min read
• Business

  Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities

  November 19, 2008

   · 

  2 min read